Role of Antidepressants in Major Depressive Disorder (MDD) Therapy: Monotherapy or Multimodal Therapy?

Listen to our expert speakers discuss major depressive disorder (MDD) in this engaging debate. Dr Charles Raison moderates, while Dr Michael Banov and Dr Michael Measom share their points of view on the role of antidepressants in the treatment of MDD.

Be sure to watch the series of videos featuring each round of this engaging debate. Don’t forget to share your thoughts and tell us who you think won each round by answering the poll questions that appear on your screen!

Introduction

Role of antidepressants in MDD therapy: monotherapy or multimodal therapy?

Meet the participants of this debate on MDD. Dr Michael Banov will support the side of antidepressants used as a monotherapy, while Dr Michael Measom will present an argument for antidepressants in a multimodal approach.

Round 1

When do you re-evaluate a patient's response to their current treatment?

In the first round of this debate, our participants tackle the issue of when to re-evaluate a patient’s response.

Round 2

Which approach is better for special populations?

In round 2 of this informative debate, the experts discuss which therapeutic approach is better for special populations struggling with MDD.

Round 3

How do you balance risk/reward, efficacy vs tolerability?

In the final round of this debate, Dr Banov and Dr Measom describe how to balance risk/reward and efficacy vs tolerability when treating patients for MDD.

Closing Arguments

Debate Conclusion

During their closing arguments, our debate participants summarize their respective thoughts from each of the three rounds to conclusively support their sides of this important debate.